Company Profiles

driven by the PitchBook Platform

Dynamix Pharmaceuticals

Description

Owner and operator of a drug development company. The company focuses on discovery and development of novel small-molecule drugs for metabolic disorders and inflammatory diseases. It uses DynamixFit, a technology, to create new drugs.

2009

Founded

PRIVATE

Status

11-50

Employees

Series A

Latest Deal Type

$10M

Latest Deal Amount

$10M

Total Amount Raised

Description

Owner and operator of a drug development company. The company focuses on discovery and development of novel small-molecule drugs for metabolic disorders and inflammatory diseases. It uses DynamixFit, a technology, to create new drugs.

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Primary Office

Rehovot Business Park Third level, Suite 308, 13 Gad Feinstein Road Rehovot 76385Israel +972 (0)8 939 6010
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Dynamix Pharmaceuticals's full profile, request a free trial.

Dynamix Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Dynamix Pharmaceuticals Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Medica Venture PartnersVenture CapitalMinority000 0000000 0000
Opal VenturesVenture CapitalMinority000 0000000 0000
Teva Pharmaceutical IndustriesCorporationMinority000 0000000 0000
Medica Venture Partners Venture Capital
Opal Ventures Venture Capital
Teva Pharmaceutical Industries Corporation

Dynamix Pharmaceuticals Executive Team (2)

NameTitleBoard
Seat
Contact
Info
Oren BeckerFounder, President, and Chief Executive Officer
Yossi Bar-OnChief Financial Officer
Oren Becker Founder, President, and Chief Executive Officer
Yossi Bar-On Chief Financial Officer
Request full access to PitchBook